BD, 570921, BD Pharmingen™ Purified NA/LE Anti-Human CD20 Obinutuzumab Biosimilar

Alternative Name: B1; Bp35; LEU-16; MS4A1
Reactivity: Human (QC Testing)
Isotype: Human IgG1, κ
Immunogen: Human CD20
Application: Flow cytometry (Routinely Tested), Cytotoxicity (Tested During Development)
Concentration: 1.0 mg/ml
Entrez Gene ID: 931
RRID: AB_3686112
Storage Buffer: No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2 µm sterile filtered. Endotoxin level is ≤0.01 EU/µg (≤0.001 ng/µg) of protein as determined by the LAL assay.
Regulatory Status: RUO
Preparation And Storage: Preparation And Storage Store undiluted at 4°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
Product Notices: Product Notices For U.S. patents that may apply, see bd.com/patents. Please refer to http://regdocs.bd.com to access safety data sheets (SDS). Please refer to www.bdbiosciences.com/us/s/resources for technical protocols. Since applications vary, each investigator should titrate the reagent to obtain optimal results. An isotype control should be used at the same concentration as the antibody of interest.